Genetic Investigations in Spontaneous Coronary Artery Dissection (SCAD)

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Mayo Clinic
Study ID
NCT01427179
Status
Recruiting
Apply to this trial

Conditions

  • SCAD
  • Spontaneous Coronary Artery Dissection

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Study Details

The purpose of the research is to identify mutations (defects in the genetic blueprint) that cause spontaneous coronary artery dissection (SCAD), in other words, spontaneous tears in blood vessels that supply the heart. Some mutations may be inherited (passed on) from a parent without an apparent blood vessel problem while others may develop for the first time in the affected person.

Key Dates

Start date
May 31, 2011
Status verified
Apr 2026
Primary completion
Dec 31, 2028
Completion
Dec 31, 2030

Study Design

Enrollment
2,000 participants (estimated)

Primary Outcome Measure

Identification of one or more gene mutation responsible for SCAD [ Time Frame: By end of study ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo ClinicRochesterMinnesota55905
Jake Nemgar
[email protected]
507-266-3180
Sharonne N. Hayes, M.D. (PRINCIPAL_INVESTIGATOR)

Find similar trials in Rochester, MN

By research site
Mayo Clinic· Rochester, MN

Related Studies